Avantor Investor Day Presentation Deck

Collaboration drives customer intimacy and customization GLP-1: INNOVATION OPPORTUNITY - - Avantor offering relevant for both synthetic and fermentation route Frequent subcutaneous dosing barrier to patient compliance - New formulations require improved process components Avantor brings a collaborative approach to innovation to meet the unique, emerging needs of therapeutic innovators 2 BIOPROCESSING NEW PRODUCT COLLABORATION Partnered with a leading GLP-1 provider to improve the purity of a formulation component to increase drug stability, which will improve dosing avantor™ 60

View entire presentation